Telehealth start-up Hims & Hers unlocks access to injectable GLP-1 medications for a fraction of the cost of brand-name weight-loss drugs Wegovy and Ozempic, expanding its holistic weight loss portfolio. Following the announcement, shares soared more than 38%.

Hims & Hers can provide patients with compounded GLP-1 drugs that start at $199 a month, about 85% less than Ozempic and Wegovy. Through a partnership with a leading US manufacturer of generic and 503B compounded injectable medications, they are also promising consistent availability.

“The core of our business is to offer a truly personalized experience that customers can trust and rely on,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “We’ve leveraged our size and scale to secure access to one of the highest-quality supplies of compounded GLP-1 injections available today. We’re passing that access and value along to our customers, who deserve the highest standard of clinical safety and efficacy to meet their goals, and we're doing it in a safe, affordable way that others can’t deliver."

According to the US Food and Drug Administration (FDA), around 70% of American adults are obese or overweight, and losing 5 to 10% of that body weight can reduce weight-related health risks, such as diabetes and cardiovascular disease.

The current Hims & Hers Weight Loss offering is tracking to eclipse $100 million in revenue by the end of 2025, as previously discussed, growing faster than any specialty in the company’s history. The company’s stock has risen more than 60% this year, before the latest weight-loss news.

“We know weight loss medications alone do not treat obesity effectively, so we’ve built a holistic weight management solution that supports customers as they combine powerful medications with healthy lifestyle habits, such as exercise, improved sleep, and eating nutritious foods,” said Dr. Patrick Carroll, Chief Medical Officer of Hims & Hers. “Our comprehensive approach to weight loss comes with support from medical providers who understand the nuance of weight gain and weight loss. We design all of our solutions to help customers be successful in the long term, and that means providing an experience personalized to the individual.”

GLP-1 injections are fulfilled and shipped from Hims & Hers' affiliated pharmacies. Once consistent supply is available through the pharmacies' wholesaler, Hims & Hers plans to make branded options available to customers, expanding the offering beyond the current oral medication kits and compounded GLP-1 injectable medications.